The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Black Stone Minerals | Common | 09225M101 | 38,209 | 5,719,924 | SH | SOLE | 5,719,924 | 0 | 0 | ||
| Unity Biotechnology Inc | Common | 91381U101 | 8,237 | 1,571,981 | SH | SOLE | 1,571,981 | 0 | 0 | ||
| Evelo Bioseciences Inc | Common | 299734103 | 5,863 | 484,953 | SH | SOLE | 484,953 | 0 | 0 | ||
| Biosig Tech Inc | Common | 09073N201 | 393 | 100,891 | SH | SOLE | 100,891 | 0 | 0 | ||
| Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC) | Common | 18507C103 | 749 | 47,148 | SH | SOLE | 47,148 | 0 | 0 | ||
| SPDR ETF | Common | 78462F103 | 6,173 | 16,511 | SH | SOLE | 16,511 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc | Common | 98943L107 | 18,826 | 362,459 | SH | SOLE | 362,459 | 0 | 0 | ||
| Exact Sciences Corp | Common | 30063P105 | 173 | 1,304 | SH | SOLE | 1,304 | 0 | 0 | ||
| Sorento Therapeutics | Common | 83587F202 | 4,493 | 657,877 | SH | SOLE | 657,877 | 0 | 0 | ||